The MarketWatch News Department was not involved in the creation of this content.-- Precede Bio Insight debuts as a first-of-its-kind product enabling genome-wide inference of gen ...

Short interval circulating tumor DNA (ctDNA) kinetics as a predictor of tumor response in patients with gastrointestinal (GI) cancer receiving immune checkpoint inhibitor (ICI)-based treatment. This ...

GeneCentric, a company making precision medicine more precise by bringing gene expression biology to liquid biopsy, today announced that it will present three posters at the American Association for ...

According to MarketsandMarkets™, the Gene Expression Analysis Market is projected to grow from about USD 4.23 billion in 2026 to USD 5.93 billion by 2031, at a CAGR of 7.0%.

For the first time ever, NTNU researchers have identified new characteristics of aggressive prostate cancer. The research lays a foundation for the possibility that aggressive prostate cancer can ...

Investigating the tumor microenvironment and neoadjuvant therapy response in HER2-positive breast cancer with invasive micropapillary carcinoma component. This is an ASCO Meeting Abstract from the ...

Researchers at Karolinska Institutet have developed CDKPredX, a gene expression-based model that identifies breast cancer tumors unlikely to respond to pre-surgery chemotherapy but more responsive to ...

The rapid advancement of spatial and single-cell omics technologies has revolutionized molecular biosciences by enabling high-resolution profiling of gene ...

A robust and quantitative map links chromatin modification and gene expression of cells during zebrafish embryogenesis.

According to MarketsandMarkets, the Gene Expression Analysis Market is projected to grow from about USD 4.23 billion in 2026 to USD 5.93 billion ...